Core Viewpoint - TianKang Biological (002100) maintains a "buy" rating due to stable pig farming operations and recovery in protein and oil business profitability [1] Group 1: Financial Performance - In H1 2025, the company reported revenue of 8.847 billion yuan, a year-on-year increase of 10.68%, and a net profit attributable to shareholders of 338 million yuan, up 22.27% year-on-year [1] - Q2 2025 revenue was 4.666 billion yuan, with a net profit of 190 million yuan, reflecting a year-on-year decrease of 14.59% [1] - The profit forecasts for 2025-2027 have been adjusted to 677 million, 913 million, and 1.576 billion yuan respectively, with corresponding EPS of 0.50, 0.67, and 1.15 yuan [1] Group 2: Pig Farming Operations - The pig farming business generated 2.849 billion yuan in revenue in H1 2025, a slight decrease of 0.95% year-on-year, with a gross margin of 11.78%, an increase of 1.55 percentage points [2] - The number of pigs sold reached 1.5282 million heads, marking a year-on-year increase of 9.05% [2] - The company aims to reduce the full-year cost to below 13 yuan per kilogram, with current costs around 13 yuan per kilogram [2] Group 3: Feed and Other Businesses - The feed business reported revenue of 2.434 billion yuan in H1 2025, down 14.24% year-on-year, with a gross profit of 246 million yuan, a decrease of 35.17% [3] - The corn storage business generated 1.305 billion yuan in revenue, up 72.32% year-on-year, while the protein and oil processing business saw revenue of 1.449 billion yuan, an increase of 97.60% year-on-year [3] - The overall profit level has improved due to the recovery in corn storage and protein oil processing profitability [3]

公司点评 | 华统股份 25H1 生猪出栏量同比增长，养殖成本下降助力业绩扭亏 证券研究报告 2025 年 08 月 28 日 华统股份（002840.SZ）25 年半年报点评 事件：公司发布 25 年半年报。25H1 公司实现营收/归母净利润 42.44/0.76 亿元，同比+1.89%/+163.98%，基本 EPS 为 0.11 元。25Q2，公司实现营 收/归母净利润 21.65/0.42 亿元，同比-0.19%/+9.75%。 25H1 业绩同比扭亏，养殖成本下降助力生猪养殖业务实现盈利。25H1/25Q2 公司生猪销量为 127.12/60.9 万头，同比+15.91%/+9.79%。其中仔猪销量 3.3/0 万头，25H1 仔猪销量同比-75.16%，仔猪占生猪比重为 2.60%，同比 -7.37pct。公司发力重点是提升育肥端产能利用率，生猪出栏量同比上升， 仔猪外销量同比明显下滑。25H1/25Q2 公司加权生猪销售均价约为 14.8/14.5（元/公斤），同比-3.61%/-11.93%。尽管销售均价同比小幅下滑， 但公司提升养殖效率，降低生猪养殖成本，使得生猪业务实现盈利。 25H1 屠 ...

Group 1: Livestock Operations - The company's current total cost for pig farming is approximately 13.3 RMB/kg, with expectations for continued cost reduction this year. The target for pig output is around 2.3 million heads [2] - The current stock of breeding sows has not increased, and the company plans to improve production performance while maintaining total breeding numbers by updating and eliminating existing sows [2] - The company has established a four-color zoning prevention and control system to monitor pig health in response to recent severe weather challenges [2] Group 2: Disease Management - The company is conducting research and optimization of the serum acclimatization program for blue ear disease, which significantly impacts pig health. The overall experimental cycle is lengthy, but progress is ongoing [2] - The company is enhancing the overall health and safety of pigs through nutritional health and disease prevention measures [2] Group 3: Business Overview - The company operates in two business models: collaboration with top-tier IPs for product design and promotion, and partnerships with mid-tier IPs to create proprietary products. Recent events include a concert and an art exhibition [3] - The company plans to launch two product lines this year: co-branded products with top-tier IPs and its own series of toy products [3] Group 4: Real Estate and Financial Status - As of June 2025, the company's real estate inventory stands at 590 million RMB, with ongoing efforts to digest existing stock. Only a few projects remain for sale [3] - The company's asset-liability ratio has decreased compared to the beginning of the year, with a focus on non-interest-bearing liabilities. The operational situation in livestock farming is stable, leading to a positive outlook for further improvement in the asset-liability ratio [3]

Investment Rating - The investment rating for the company is "Buy" [1] Core Views - The company reported a strong performance in 2024, with total revenue reaching 104.906 billion yuan, a year-on-year increase of 16.66%, and a net profit attributable to shareholders of 9.245 billion yuan, up 244.68% year-on-year [6][7] - The pig farming segment has turned profitable, becoming the core driver of profit growth, with a total pig output of 30.1827 million heads, an increase of 14.93% year-on-year, and an average selling price of 16.71 yuan/kg, up 12.83% year-on-year [6][7] - The poultry segment demonstrated resilience, with chicken output of 1.208 billion heads, a year-on-year increase of 2.09%, despite a 4.60% decline in average selling price to 13.06 yuan/kg [6][7] Summary by Relevant Sections Financial Performance - The company forecasts revenue for 2024, 2025, and 2026 to be 104.402 billion yuan, 101.369 billion yuan, and 108.541 billion yuan respectively, with net profits of 9.257 billion yuan, 6.704 billion yuan, and 9.952 billion yuan respectively [4][7] - Earnings per share (EPS) are projected to be 1.39 yuan, 1.01 yuan, and 1.50 yuan for the years 2024, 2025, and 2026 respectively [4][7] Cost Management - The comprehensive cost of pig farming is expected to decrease further, with a target of 13 yuan/kg for 2025, providing a safety net for the company's performance amid price fluctuations [6][7] - In the poultry segment, the company managed to reduce costs more significantly than the decline in chicken prices, leading to profit growth despite market pressures [6][7] Market Outlook - The recovery of pig farming capacity is expected to be slow, limiting supply growth in 2025, which will constrain price adjustments [6][7] - The company aims to maintain its leading position in the industry through efficient production and cost management strategies [6][7]